Levine L A, Estrada C R, Morgentaler A
Department of Urology, Rush-Presbyterian-St. Luke's Medical Center, 1725 West Harrison Street, Chicago, IL 60612, USA.
J Urol. 2001 Sep;166(3):932-7.
We reviewed the experience with the 2-piece Ambicor penile prosthesis (American Medical Systems, Minnetonka, Minnesota) at 2 medical centers to investigate its mechanical reliability and complication rates as well as patient and partner satisfaction with the device.
From 1995 through 1999, 131 men underwent implantation of an Ambicor penile prosthesis at 2 medical centers. We performed a 3-part study consisting of a retrospective clinical record review, mailed patient and partner questionnaire, and mailed modified patient and partner Erectile Dysfunction Inventory of Treatment Satisfaction questionnaire. Mean followup was 43.4 months (range 12 to 73).
All 131 men had a history consistent with an organic etiology of erectile dysfunction, including vascular disease in 62%, radical retropubic prostatectomy in 17%, Peyronie's disease in 15%, neophallus construction in 4% and radical pelvic surgery in 2%. Mean patient age was 56.8 years (range 22 to 76) at implantation. Overall there were complications in 10 cases (7.6%), including infection, hematoma and mechanical failure in 6 (4.6%), 1 (0.7%) and 3 (2.3%), respectively. A total of 112 men (85%) and 91 partners completed the questionnaire. All patient respondents still had an Ambicor prosthesis implanted and 96.4% had erection suitable for coitus. Overall patient and partner satisfaction was 96.4% and 91.2%, respectively. Of the respondents 92.9% of patients and 90.1% of partners would recommend the device to others. Of the 85 men (65%) and 46 partners who completed the modified Erectile Dysfunction Inventory of Treatment Satisfaction survey 90.6% and 82.6%, respectively, were satisfied or very satisfied overall with the penile prosthesis.
The Ambicor penile prosthesis is associated with a low complication rate and reliable mechanical function. High satisfaction was reported by patients and partners.
我们回顾了两家医疗中心使用两件式安必可阴茎假体（美国医疗系统公司，明尼苏达州明尼通卡）的经验，以调查其机械可靠性、并发症发生率以及患者和伴侣对该装置的满意度。
1995年至1999年期间，131名男性在两家医疗中心接受了安必可阴茎假体植入手术。我们进行了一项分为三个部分的研究，包括回顾性临床记录审查、邮寄给患者和伴侣的问卷，以及邮寄经修改的患者和伴侣治疗满意度勃起功能障碍量表问卷。平均随访时间为43.4个月（范围12至73个月）。
所有131名男性均有与勃起功能障碍器质性病因相符的病史，其中血管疾病占62%，耻骨后根治性前列腺切除术占17%，佩罗尼氏病占15%，阴茎再造占4%，盆腔根治性手术占2%。植入时患者平均年龄为56.8岁（范围22至76岁）。总体上有10例（7.6%）出现并发症，分别为感染6例（4.6%）、血肿1例（0.7%）和机械故障3例（2.3%）。共有112名男性（85%）和91名伴侣完成了问卷。所有参与问卷调查的患者仍植入着安必可假体，96.4%的患者勃起功能适合性交。患者和伴侣的总体满意度分别为96.4%和91.2%。在受访者中，92.9%的患者和90.1%的伴侣会向他人推荐该装置。在完成经修改的治疗满意度勃起功能障碍量表调查的85名男性（65%）和46名伴侣中，分别有90.6%和82.6%对阴茎假体总体满意或非常满意。
安必可阴茎假体并发症发生率低，机械功能可靠。患者和伴侣报告的满意度较高。
